Advertisement

Update 1989 pp 511-517 | Cite as

Prevention of Sudden Death Following Myocardial Infarction

  • L. Szekeres
Conference paper
Part of the Update in Intensive Care and Emergency Medicine book series (UICM, volume 8)

Abstract

In the industrialized countries nearly one third of mortality among men under the age of 65 years is due to sudden cardiac death (SCD) following acute myocardial infarction (AMI) [1, 2] and nearly 60% of post-infarction sudden death is due to ventricular fibrillation [3].

Keywords

Ventricular Fibrillation Electrical Instability Reperfusion Arrhythmia Free Fatty Acid Composition Tanoic Acid 
These keywords were added by machine and not by the authors. This process is experimental and the keywords may be updated as the learning algorithm improves.

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. 1.
    Szekeres L (1986) Sudden death due to acute myocardial infarction. CRC Press Inc, Boca Raton, FloridaGoogle Scholar
  2. 2.
    Szekeres L (1986) Pharmacotherapy of sudden cardiac death due to acute myocardial ischaemia. Cor Vasa 28:123–137PubMedGoogle Scholar
  3. 3.
    Hinkle LE (1982) Short term risk factors for sudden death. In: Greenberg HM, Dwyer EM (eds) Ann N Y Acad Sci 382:22–39Google Scholar
  4. 4.
    Szerkeres L, Leprán I, Koltai M, (1980) Influence of linoleic acid rich diet on the incidence of arrhythmias and death in the acute phase of myocardial infarction in conscious rats. In: Förster W (ed) Prostaglandins and thromboxanes. VEB Gustav Fischer, Jena, GDR, pp 33–36Google Scholar
  5. 5.
    Leprán I, Nemecz GY, Koltai M, Szekeres L (1981) Effect of linoleic acid rich diet on the acute phase of coronary occlusion in conscious rat. Influence of indomethacin and aspirin. J Cardiovasc Pharmacol 3:847–854PubMedCrossRefGoogle Scholar
  6. 6.
    Szekeres L, Leprán I, Boros E, Takáts I, Koltai M (1982) The effect of non-steroidal antiinflammatory drugs and of linoleic acid-rich diet on early arrhythmias resulting from myocardial ischaemia. In: Parratt JR (ed) Early arrhythmias resulting from myocardial ischaemia. Macmillan, London, pp 239–249Google Scholar
  7. 7.
    Szekeres L (1987) Cardioprotection by antiischaemic and cytoprotective drugs. In: Jacob R, Just HJ, Holubarsch Ch (eds) Cardiac energetics. Steinkopff, Darmstadt, pp 325–334Google Scholar
  8. 8.
    Dyerberg J, Bang HO, Stoffersen E, Moneada S, Vane JR (1978) Eicosapentaenoic acid and prevention of thrombosis and atherosclerosis? Lancet 2 117–119PubMedCrossRefGoogle Scholar
  9. 9.
    Dyerberg J, Bang HO (1982) A hypothesis on the development of acute myocardial infarction in Greenlanders. Scand J Clin Lab Invest 42 (Suppl 161):7–13CrossRefGoogle Scholar
  10. 10.
    Expert Panel (1988) Arch Intern Med 148:36–69CrossRefGoogle Scholar
  11. 11.
    Wainwright CL, Parratt JR (1988) An antiarrhythmic effect of adenosine during myocardial ischemia and reperfusion. Eur J Pharmacol 45:183–194CrossRefGoogle Scholar
  12. 12.
    Szentmiklósi AJ, Németh M, Szegi J, Papp JGy, Szekeres L (1980) Effect of adenosine on sino-atrial and ventricular automaticity of the guinea pig. Naunyn-Schmiedebergs Arch Pharmacol 311:147–149PubMedCrossRefGoogle Scholar
  13. 13.
    Guthrie JR, Nayler WG (1967) Interaction between caffeine and adenosine on calcium exchange ability in mammalian atria. Arch Int Pharmacodyn Ther 170:249–255PubMedGoogle Scholar
  14. 14.
    Szekeres L, Koltai M, Pataricza J, Takáts I, Udvary É (1984) On the late antiischaemic action of the stable PgI2 analogue: 7-oxo-PgI2-Na and its possible mode of action. Biomed Biochim Acta 43:135–142Google Scholar
  15. 15.
    Udvary É, Szekeres L (1985) Prostacyclin: Antiischaemic or cardioprotective? In: Kecskeméti V, Gyires K, Kovács G, (eds) Advances in pharmacological research and practice, sect 7. Prostanoids, Akadémisi Kiadó, Budapest, pp 333–339Google Scholar
  16. 16.
    Szekeres L, Németh M, Papp JGy, Udvary É, Végh Á, Virágh L (1988) Neue Entwicklungen der antiarrhythmischen Therapie. In: Lüderitz B, Antoni H (eds) Perspektiven der Arrhythmiebehandlung. Springer, Berlin Heidelberg New York Tokyo, pp 24–35CrossRefGoogle Scholar
  17. 17.
    Udvary É, Végh Á, Szekeres L (1988) 7-oxo-PgI2-induced late appearing and long lasting antiischemic action in dogs. Pharmacol-Res. Communications 20 (Suppl 1): 171–173CrossRefGoogle Scholar
  18. 18.
    van Aken WG (1983) Do anticoagulants lower morbidity and mortality after myocardial infarction? In: Kulbertus HE, Wellens HJJ (eds) The first year after a myocardial infarction. Futura Publ Comp, Mount Kisco New York, pp 313–321Google Scholar
  19. 19.
    Hirch J (1983) Antiplatelet agents in myocardial infarction. In: Kulbertus HE, Wellens HJJ (eds) The first year after a myocardial infarction. Futura Publ Comp, Mount Kisco New York, pp 289–313Google Scholar
  20. 20.
    de Caterina R, Giannessi D, Bernini W et al (1985) Low-dose aspirin in patients recovering from myocardial infarction. Evidence for a selective inhibition of thromboxane-related platelet function. Eur Heart J 6:409–417PubMedGoogle Scholar
  21. 21.
    Förster W, Hoffmann W (1987) Two-year follow-up study on the use of acetylsalicylic acid to prevent reinfarction and cardiac death in patients from the Cottbus region. In: Papp JGy (ed) Cardiovasc. Pharm. Akadémiai Kiadó, Budapest, pp 457–471Google Scholar

Copyright information

© Springer-Verlag Berlin Heidelberg 1989

Authors and Affiliations

  • L. Szekeres

There are no affiliations available

Personalised recommendations